As of May 2024 Omeros Corporation has a market cap of $0.24 Billion. This makes Omeros Corporation the world's 6804th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.24 B | 17.54% |
2023 | $0.20 B | 45% |
2022 | $0.14 B | -64.8% |
2021 | $0.40 B | -54.29% |
2020 | $0.88 B | 15.36% |
2019 | $0.76 B | 39.87% |
2018 | $0.54 B | -41.46% |
2017 | $0.93 B | 119.09% |
2016 | $0.42 B | -28.85% |
2015 | $0.59 B | -29.36% |
2014 | $0.84 B | 147.15% |
2013 | $0.34 B | 155.01% |
2012 | $0.13 B | 52.19% |
2011 | $88.31 M | -51.11% |
2010 | $0.18 B | 20.88% |
2009 | $0.14 B |
On May 16th, 2024 the market cap of Omeros Corporation was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $371.30 B | 153,567.66% | ๐บ๐ธ USA |
Pfizer PFE | $163.87 B | 67,722.62% | ๐บ๐ธ USA |
Genetic Technologies GENE | $10.94 M | -95.47% | ๐ฆ๐บ Australia |
Eterna Therapeutics ERNA | $11.46 M | -95.25% | ๐บ๐ธ USA |